Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up 0.46% Nasdaq Up 0.28%
Streaming
Ticker Tape: On

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS

7.53 Down 0.04(0.53%) 3:07PM EDT - Nasdaq Real Time Price

Add to Portfolio
Prev Close:7.57
Open:7.73
Bid:7.54 x 600
Ask:7.55 x 1100
1y Target Est:7.79
Beta:1.45
Next Earnings Date: 5-Aug-13HALO Earnings announcement
Day's Range:7.42 - 7.92
52wk Range:3.86 - 9.92
Volume:1,174,073
Avg Vol (3m):1,351,200
Market Cap:846.49M
P/E (ttm):N/A
EPS (ttm):-0.51
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
HALODown 0.53%846.49M
RHHBYN.MXUp 0.14%2.66T
SHP.LUp 2.35%11.77B
SUNPHARMA.NSUp 0.83%1.01T
GILD.MXUp 0.11%1.04T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :-0.57
Quarterly EPS Est (Jun-13) :-0.14
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human enzymes. Its research focuses on human enzymes that transiently modify tissue under the skin to facilitate the delivery ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback